XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.4
Employee Benefit Plans (Tables)
6 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

 

 

December 31,
2024

 

 

June 30,
2024

 

2013 Equity Incentive Plan shares available for grant

 

 

11,092

 

 

 

13,414

 

Employee stock options and awards outstanding

 

 

8,619

 

 

 

7,562

 

2014 Employee Stock Purchase Plan

 

 

6,662

 

 

 

7,130

 

Total shares reserved for issuance

 

 

26,373

 

 

 

28,106

 

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

December 31,
2024

 

 

December 31,
2023

 

 

December 31,
2024

 

 

December 31,
2023

 

Cost of product revenues

 

$

680

 

 

$

464

 

 

$

1,298

 

 

$

947

 

Cost of subscription and support revenues

 

 

798

 

 

 

749

 

 

 

1,487

 

 

 

1,615

 

Research and development

 

 

4,467

 

 

 

4,435

 

 

 

8,680

 

 

 

8,812

 

Sales and marketing

 

 

7,596

 

 

 

7,535

 

 

 

14,478

 

 

 

14,523

 

General and administrative

 

 

7,911

 

 

 

7,774

 

 

 

15,276

 

 

 

14,979

 

Total share-based compensation expense

 

$

21,452

 

 

$

20,957

 

 

$

41,219

 

 

$

40,876

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2024 (in thousands, except per share amount and contractual term):

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at June 30, 2024

 

 

1,073

 

 

$

6.58

 

 

 

1.75

 

 

$

7,376

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(195

)

 

 

6.40

 

 

 

 

 

 

 

Canceled

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2024

 

 

878

 

 

$

6.62

 

 

 

1.39

 

 

$

8,886

 

Vested and expected to vest at December 31, 2024

 

 

878

 

 

$

6.62

 

 

 

1.39

 

 

$

8,886

 

Exercisable at December 31, 2024

 

 

878

 

 

$

6.62

 

 

 

1.39

 

 

$

8,886

 

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2024 (in thousands, except grant date fair value):

 

 

 

Number of Shares

 

 

Weighted- Average Grant Date Fair Value

 

 

Aggregate Fair Value

 

Non-vested stock awards outstanding at June 30, 2024

 

 

6,489

 

 

$

22.65

 

 

 

 

Granted

 

 

4,191

 

 

 

15.82

 

 

 

 

Released

 

 

(2,662

)

 

 

20.47

 

 

 

Canceled

 

 

(277

)

 

 

21.62

 

 

 

 

Non-vested stock awards outstanding at December 31, 2024

 

 

7,741

 

 

$

19.83

 

 

 

 

Stock awards expected to vest at December 31, 2024

 

 

7,741

 

 

$

19.83

 

 

$

153,538

 

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs) The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant, as indicated in the table below. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

Level

Relative TSR

Shares Vested

Below Threshold

TSR is less than the Index by more than 37.5 percentage points

0%

Threshold

TSR is less than the Index by 37.5 percentage points

25%

Target

TSR equals the Index

100%

Maximum

TSR is greater than the Index by 25 percentage points or more

150%

TSR
Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

 

 

 

 

Employee Stock Purchase Plan

 

 

 

 

 

Six Months Ended

 

 

 

 

 

December 31,
2024

 

 

December 31,
2023

 

 

Expected term

 

 

0.5 years

 

 

0.5 years

 

 

Risk-free interest rate

 

 

 

5.04

%

 

 

5.54

%

 

Volatility

 

 

 

36

%

 

 

42

%

 

Dividend yield

 

 

 

%

 

 

%